Supplemental Figures from Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
Brendan J. Guercio, Eugene J. Pietzak, Vignesh Ravichandran, Jie‐Fu Chen et autres
0 citations
Cassidy C. Cobbs
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
41Publications signalées
219Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Childhood Cancer Survivors' Quality of LifeNeutropenia and Cancer InfectionsHyperglycemia and glycemic control in critically ill and hospitalized patientsCancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment
Les publications récentes
Data from Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
Brendan J. Guercio, Eugene J. Pietzak, Vignesh Ravichandran, Jie‐Fu Chen et autres
0 citations
Table S1 from Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
Brendan J. Guercio, Eugene J. Pietzak, Vignesh Ravichandran, Jie‐Fu Chen et autres
0 citations
Supplementary Data from Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
Brendan J. Guercio, Eugene J. Pietzak, Vignesh Ravichandran, Jie‐Fu Chen et autres
0 citations
Intracranial pharmacokinetics and resistance mechanisms of tucatinib in patients with HER2+/mutant solid tumors and brain metastasis: Results from the WinHER2 study (NCT05892068).
Emanuela Ferraro, Vanessa R. Thompson, Robert J. Young, Sohrab P. Shah et autres
it, us (code pays fourni par la source)
0 citations
Journal of Clinical Oncology
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
Brendan J. Guercio, Eugene J. Pietzak, Vignesh Ravichandran, Jie-Fu Chen et autres
us, ie (code pays fourni par la source)
1 citation
Clinical Cancer Research
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology
Dylan Domenico, Gunes Gundem, Max F. Levine, Juan Arango Ossa et autres
us, jp, gb (code pays fourni par la source)
2 citations
Nature Communications
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors
Neerav Shukla, Karmelina Charalambous, Shanita Li, Kaitlyn Ko et autres
us (code pays fourni par la source)
0 citations
Blood Cancer Journal
Author Correction: Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers
Neerav Shukla, Max F. Levine, Gunes Gundem, Dylan Domenico et autres
us (code pays fourni par la source)
0 citations
Nature Communications
Cell-Free DNA Blood Collection Tubes Crosslinking Cellular DNA Impeding Nanopore Long-Read Sequencing
Stephanie Chrysanthou, Trishala Karmacharya, Juan Li, Chen Lu et autres
us (code pays fourni par la source)
2 citations
Data from Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
Michael D. Kinnaman, Simone Zaccaria, Alvin P. Makohon-Moore, Brian J. Arnold et autres
0 citations
Supplementary Data from Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
Michael D. Kinnaman, Simone Zaccaria, Alvin P. Makohon-Moore, Brian J. Arnold et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.